Literature DB >> 20019193

Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.

Hiaki Sato1, Takashi Oka, Yoko Shinnou, Takami Kondo, Kana Washio, Masayuki Takano, Katsuyoshi Takata, Toshiaki Morito, Xingang Huang, Maiko Tamura, Yuta Kitamura, Nobuya Ohara, Mamoru Ouchida, Koichi Ohshima, Kenji Shimizu, Mitsune Tanimoto, Kiyoshi Takahashi, Masao Matsuoka, Atae Utsunomiya, Tadashi Yoshino.   

Abstract

Aberrant CpG island methylation contributes to the pathogenesis of various malignancies. However, little is known about the association of epigenetic abnormalities with multistep tumorigenic events in adult T cell leukemia/lymphoma (ATLL). To determine whether epigenetic abnormalities induce the progression of ATLL, we analyzed the methylation profiles of the SHP1, p15, p16, p73, HCAD, DAPK, hMLH-1, and MGMT genes by methylation specific PCR assay in 65 cases with ATLL patients. The number of CpG island methylated genes increased with disease progression and aberrant hypermethylation in specific genes was detected even in HTLV-1 carriers and correlated with progression to ATLL. The CpG island methylator phenotype (CIMP) was observed most frequently in lymphoma type ATLL and was also closely associated with the progression and crisis of ATLL. The high number of methylated genes and increase of CIMP incidence were shown to be unfavorable prognostic factors and correlated with a shorter overall survival by Kaplan-Meyer analysis. The present findings strongly suggest that the multistep accumulation of aberrant CpG methylation in specific target genes and the presence of CIMP are deeply involved in the crisis, progression, and prognosis of ATLL, as well as indicate the value of CpG methylation and CIMP for new diagnostic and prognostic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019193      PMCID: PMC2797900          DOI: 10.2353/ajpath.2010.090236

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.

Authors:  K Nosaka; M Maeda; S Tamiya; T Sakai; H Mitsuya; M Matsuoka
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

Authors:  J F Costello; M C Frühwald; D J Smiraglia; L J Rush; G P Robertson; X Gao; F A Wright; J D Feramisco; P Peltomäki; J C Lang; D E Schuller; L Yu; C D Bloomfield; M A Caligiuri; A Yates; R Nishikawa; H Su Huang; N J Petrelli; X Zhang; M S O'Dorisio; W A Held; W K Cavenee; C Plass
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 3.  Deregulation of cell-signaling pathways in HTLV-1 infection.

Authors:  William W Hall; Masahiro Fujii
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

4.  Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma.

Authors:  Misuzu Shimakage; Nobumasa Inoue; Kohichi Ohshima; Kunimitsu Kawahara; Naoki Yamamoto; Takashi Oka; Yukihiro Tambe; Kazuta Yasui; Kayoko Matsumoto; Masuo Yutsudo; Hirokazu Inoue
Journal:  Int J Oncol       Date:  2007-06       Impact factor: 5.650

Review 5.  Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.

Authors:  M Yoshida
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines.

Authors:  Y Ariyama; T Mori; T Shinomiya; T Sakabe; Y Fukuda; A Kanamaru; Y Yamada; M Isobe; M Seto; Y Nakamura; J Inazawa
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

Review 7.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy.

Authors:  Michael Haberland; Rusty L Montgomery; Eric N Olson
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

Review 8.  Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.

Authors:  Takuo Katsumoto; Naomi Yoshida; Issay Kitabayashi
Journal:  Cancer Sci       Date:  2008-08       Impact factor: 6.716

Review 9.  MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.

Authors:  M Fabbri; R Garzon; M Andreeff; H M Kantarjian; G Garcia-Manero; G A Calin
Journal:  Leukemia       Date:  2008-03-06       Impact factor: 11.528

Review 10.  Cancer genetics of epigenetic genes.

Authors:  Ahmad Miremadi; Mikkel Z Oestergaard; Paul D P Pharoah; Carlos Caldas
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

View more
  28 in total

1.  Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

2.  Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.

Authors:  Kai Ding; Xiaoshuang Chen; Yihao Wang; Hui Liu; Wenjing Song; Lijuan Li; Guojin Wang; Jia Song; Zonghong Shao; Rong Fu
Journal:  Int J Clin Oncol       Date:  2017-02-16       Impact factor: 3.402

3.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

Review 4.  Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules.

Authors:  Pilar Blancafort; Jian Jin; Stephen Frye
Journal:  Mol Pharmacol       Date:  2012-11-13       Impact factor: 4.436

5.  Notable roles of EZH2 and DNMT1 in epigenetic dormancy of the SHP1 gene during the progression of chronic myeloid leukaemia.

Authors:  Jing Wang; Luoming Hua; Ming Guo; Lin Yang; Xiaojun Liu; Yanmeng Li; Xiaoyan Shang; Jianmin Luo
Journal:  Oncol Lett       Date:  2017-04-19       Impact factor: 2.967

6.  Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.

Authors:  Kozue Ejima-Yamada; Yumi Oshiro; Seiichi Okamura; Tomoaki Fujisaki; Yasuhito Mihashi; Kazuo Tamura; Tomoko Fukushige; Masaru Kojima; Kazutoshi Shibuya; Morishige Takeshita
Journal:  Virchows Arch       Date:  2016-11-18       Impact factor: 4.064

Review 7.  Dissecting DNA hypermethylation in cancer.

Authors:  Marcos R H Estécio; Jean-Pierre J Issa
Journal:  FEBS Lett       Date:  2010-12-10       Impact factor: 4.124

Review 8.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.

Authors:  Toshiki Watanabe
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

9.  Array-based DNA methylation profiling for breast cancer subtype discrimination.

Authors:  Ilse Van der Auwera; Wayne Yu; Liping Suo; Leander Van Neste; Peter van Dam; Eric A Van Marck; Patrick Pauwels; Peter B Vermeulen; Luc Y Dirix; Steven J Van Laere
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

Review 10.  Human viral oncogenesis: a cancer hallmarks analysis.

Authors:  Enrique A Mesri; Mark A Feitelson; Karl Munger
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.